
EatFit Lab, listed on Zomato, is marketing several nutrient-focused dishes as “GLP-1 friendly and high protein”.
The Delhi-NCR cloud kitchen’s use of GLP-1—a class of prescription medicines for diabetes and obesity—as a menu label has prompted mixed responses online. Its offerings include salads, a fibre-rich whole-wheat pasta bowl and a low-GI quinoa salad.
A Delhi-NCR cloud kitchen listed on Zomato as EatFit Lab is describing its menu as “GLP-1 friendly and high protein”, bringing a prescription-medicine term into food delivery marketing.
The menu includes high-protein vegetable, chicken and avocado salads; a low-GI quinoa salad; a “GLP1 Friendly Fiber Rich Whole Wheat Pasta Bowl”; and a “High Zinc Khus Khus Burrito Bowl”. GLP-1 refers to a class of prescription medicines used in the treatment of diabetes and obesity.
Shreeum Rakheja, who encountered the listing while ordering a sandwich, questioned the wording in an Instagram Reel posted on August 21. “A medicine’s name is in the title of a restaurant, and we are okay with this. We have trendified a medicine,” she said.
Responses to her post were divided. Some users objected to using a medicine’s name as a restaurant marketing term, while others said nutrient-dense meals could be useful for people taking such medicines. EatFit Lab was unavailable for comment.
GTK covers the news, people, culture, neighbourhoods, civic life and food shaping India’s cities. Better Starts With Us.